New NICE Guidance for Diabetes

NICE have issued two draft guidelines on diabetes care. Of the two documents, one focuses on adults with type 1 diabetes and the other concentrates on children and young adults, with either type 1 or type 2. 

Sparking this call for updated guidance, the last was issued in 2004, is the worrying evidence that rates of diabetes diagnosis are swelling profusely throughout the country. Research shows that there are over 370,000 type 1 diabetes sufferers across the country, and 450 children with type 2. 

The guidance for adults focuses on greater personalisation of care, and encourages a structured education program for diabetes sufferers to improve understanding. It also specifies achievable individualised targets for HbA1c levels and plasma glucose. The guidance supports testing at least 4 times a day on a routine basis for blood glucose and up to ten times if the patient fulfils any further conditions e.g. before and after sport, if they aren’t achieving HbA1c targets, during illness, pregnancy (more here). 

For children, there have been major changes to the routine management of type 1 diabetes since 2004 when the last guidance was issued. The guidance outlines what these are -  including technology advances, and it is the first guidance to recommend attempting to achieve an HbA1c level in the normal range and near normoglycaemia . Increasing information and education for children and their families is recommended, as well as ongoing access to mental health professionals. 
The guideline development group (GDG) believes that by implementing the strict blood glucose control recommended in this guideline, improvements can be made to diabetes care that reduce the impact of the condition on the future health of children and young people.

Importantly the guideline development group have said that ‘Preparations should also be made for the child or young person’s transition to adult services, which have a somewhat different model of care and evidence base’. This has previously been an issue for development, and BIVDA are pleased to see that this has been picked up. 

BIVDA will be responding to this guidance on behalf of the IVD industry. Please contact Rebecca to input into this response. 


Ahead of Blood Cancer Awareness Month in September, this week’s #BIVDAblog is raising awareness of ...

Read More >

The Chancellor, Rishi Sunak, has announced the Budget in Parliament this afternoon. Several policies...

Read More >

In a speech to the All Party Parliamentary Group for Life Sciences in May, BIVDA’s Chairman, Darren...

Read More >

In the second of our AMR guest blog double bill, this piece courtesy of the Longitude Prize, written...

Read More >

Prime Minister David Cameron, has announced a review into antimicrobial resistance, and why so few d...

Read More >

With the rising prominence of tumour biomarkers and genetic profiling, it is clear that the profile ...

Read More >